CD38 in the pathogenesis of allergic airway disease: Potential therapeutic targets.
about
Meat Intake and the Dose of Vitamin B3 - Nicotinamide: Cause of the Causes of Disease Transitions, Health Divides, and Health Futures?Second messenger analogues highlight unexpected substrate sensitivity of CD38: total synthesis of the hybrid "L-cyclic inosine 5'-diphosphate ribose".CD38 knockout suppresses tumorigenesis in mice and clonogenic growth of human lung cancer cells.Specific cyclic ADP-ribose phosphohydrolase obtained by mutagenic engineering of Mn2+-dependent ADP-ribose/CDP-alcohol diphosphatase.The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging.
P2860
CD38 in the pathogenesis of allergic airway disease: Potential therapeutic targets.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
CD38 in the pathogenesis of allergic airway disease: Potential therapeutic targets.
@en
CD38 in the pathogenesis of allergic airway disease: Potential therapeutic targets.
@nl
type
label
CD38 in the pathogenesis of allergic airway disease: Potential therapeutic targets.
@en
CD38 in the pathogenesis of allergic airway disease: Potential therapeutic targets.
@nl
prefLabel
CD38 in the pathogenesis of allergic airway disease: Potential therapeutic targets.
@en
CD38 in the pathogenesis of allergic airway disease: Potential therapeutic targets.
@nl
P2093
P2860
P1476
CD38 in the pathogenesis of allergic airway disease: Potential therapeutic targets.
@en
P2093
Alonso G P Guedes
Deepak A Deshpande
Frances E Lund
Mathur S Kannan
Timothy F Walseth
P2860
P304
P356
10.1016/J.PHARMTHERA.2016.12.002
P577
2016-12-07T00:00:00Z